Milestone Scientific(MLSS)

Search documents
Milestone Scientific Announces Medicare Price Assignment for the CompuFlo® Epidural System in Texas, Pennsylvania, New Jersey, Maryland, Colorado, Oklahoma, Louisiana, Arkansas, Mississippi, New Mexico, District of Columbia, and Delaware
Newsfilter· 2024-07-23 12:30
ROSELAND, N.J., July 23, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Novitas Solutions, Inc. (Novitas), a Jurisdictional Medicare Administrative Contractor (JMAC), has granted a Medicare Part B Physician payment rate for the Company's CompuFlo® Epidural System under the American Medical Association's (AMA) technology-specific Category III CPT® code CPT0777T (r ...
Milestone Scientific Announces Favorable Medicare Pricing for its CompuFlo® Epidural System within First JMAC Region Covering Florida
Newsfilter· 2024-07-10 12:30
ROSELAND, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced at the Sixth Annual American Society of Pain & Neuroscience Conference in Miami Beach that First Coast Service Options Inc. (FCSO), a Jurisdictional Medicare Administrative Contractor ("JMAC"), has granted favorable Medicare Part B physician price assignment across Florida for use of the Company's ...
Milestone Scientific Receives Regulatory Approval to Market CompuFlo® Epidural System in Brazil
Newsfilter· 2024-06-18 15:00
An estimated 4-5 million epidural anesthesia procedures are performed annually in Brazil; potential to expand this addressable market due to CompuFlo's technological advantages The CompuFlo® Epidural System, known for its ability to significantly reduce the morbidity and discomfort associated with traditional epidural procedures, uses the Company's patented Dynamic Pressure Sensing® technology. This real-time feedback technology ensures accurate placement and verification of the epidural needle in the epidu ...
Milestone Scientific Receives Regulatory Approval to Market CompuFlo® Epidural System in Brazil
GlobeNewswire News Room· 2024-06-18 15:00
Brazil is the 9th largest economy in the world with more than 21 million people suffering from chronic back pain An estimated 4-5 million epidural anesthesia procedures are performed annually in Brazil; potential to expand this addressable market due to CompuFlo's technological advantages Arjan Haverhals, CEO and President of Milestone Scientific, stated, "We are thrilled to bring the CompuFlo® Epidural System to Brazil, the 9th largest economy in the world, with a population of more than 200 million people ...
Milestone Scientific(MLSS) - 2024 Q1 - Earnings Call Transcript
2024-05-17 00:56
Milestone Scientific Inc. (NYSE:MLSS) Q1 2024 Results Conference Call May 16, 2024 8:30 AM ET Company Participants David Waldman - Investor Relations Arjan Haverhals - Chief Executive Officer Keisha Harcum - Controller Conference Call Participants Anthony Vendetti - the Maxim Group Operator Good morning, everyone, and welcome to the Milestone Scientific Inc. First Quarter 2024 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode and we’ll open for q ...
Milestone Scientific(MLSS) - 2024 Q1 - Quarterly Report
2024-05-15 20:01
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2024 ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14053 Milestone Scientific Inc. (Exact name of registrant as specified in its charter) Delaware 13-3545623 State or other jurisdiction of Inco ...
Milestone Scientific Schedules First Quarter 2024 Financial Results and Business Update Conference Call
GlobeNewsWire· 2024-05-13 12:30
ROSELAND, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Thursday, May 16th, 2024, to discuss the company’s financial results for the first quarter ended March 31, 2024, as well as the company’s corporate progress and other developments. The conference call will be available via telephone by ...
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within PRC Alliance Pain Relief Center in Ormond Beach, Florida
Newsfilter· 2024-04-03 12:30
PRC Alliance Pain Relief Center operates 8 locations across central Florida Dr. Bakshi reports 100% success performing Epidural Steroid Injection (ESI) procedures during evaluation period ROSELAND, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced sales of CompuFlo® Epidural disposables into PRC Alliance Pain Relief Center at Ormond B ...
Milestone Scientific(MLSS) - 2023 Q4 - Earnings Call Transcript
2024-04-01 18:43
Milestone Scientific Inc. (NYSE:MLSS) Q4 2023 Earnings Conference Call April 1, 2024 8:30 AM ET Company Participants David Waldman - Investor Relations Jan Haverhals - Chief Executive Officer Keisha Harcum - Controller Conference Call Participants Jeremy Pearlman - Maxim Group Operator Good morning, everyone and welcome to the Milestone Scientific 2023 Year-End Financial Results and Business Update Conference Call. [Operator Instructions] It is now my pleasure to turn the floor over to your host, David Wald ...
Milestone Scientific(MLSS) - 2023 Q4 - Annual Report
2024-03-29 17:44
| UNITED STATES | | | --- | --- | | SECURITIES AND EXCHANGE COMMISSION | | | Washington, D.C. 20549 | | | FORM 10-K | | | (Mark One) | | | ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | | For the fiscal year ended December 31, 2023 | | | Or | | | ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | | For the transition period from to | | | Commission file number 001-14053 | | | Milestone Scientific Inc. | | | (Exact name o ...